Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype
H. E. Wilson, D. A. Stanton, C. Montgomery, A. M. Infante, M. Taylor, H. Hazard-Jenkins, E. N. Pugacheva, E. E. Pistilli
This study identifies molecular changes in skeletal muscle caused by breast cancer, showing mitochondrial dysfunction across subtypes and no effect of treatment on gene expression.
bioRxiv · Oct 21, 2019Cancer Biology